Provides Preliminary 2014 Financial Outlook
Adjusts Previously Provided 2013 Constant Currency Revenue Growth
Range and Reaffirms 2013 Adjusted EPS Guidance
LIMERICK, Pa.--(BUSINESS WIRE)--Dec. 17, 2013--
Teleflex Incorporated (NYSE: TFX) will provide its preliminary financial
outlook for 2014 and discuss the business plans and strategic
initiatives that are expected to drive the Company’s growth and margin
expansion in 2014 and beyond at the Company’s Investor and Analyst Day
meeting today.
Benson Smith, Chairman, President and Chief Executive Officer commented,
“The Company is heading to a solid finish in 2013 and we have built
momentum in executing our strategic initiatives as we look forward to
2014. However, due to lower than expected distributor purchases,
primarily in Asia, and delays in concluding negotiations in a
distributor-to-direct conversion, we are slightly lowering our 2013
revenue growth expectations.”
Added Smith, “I am pleased to announce that this dealer negotiation
recently concluded positively for Teleflex. As a result of this, as well
as the recently completed acquisition of Vidacare, the introduction of
new products to the market, and the continued integration of LMA,
Teleflex is well-positioned to continue to exceed industry revenue
growth rates and expand adjusted operating margin and earnings per share
in 2014.”
The Company’s preliminary financial goals for 2014 include constant
currency revenue growth of 7% to 9% and adjusted diluted earnings per
share from continuing operations in the range of $5.35 to $5.55.
In addition to providing its preliminary outlook for 2014, the Company
lowered its previously provided 2013 constant currency revenue growth
range from 8.5% to 10% to 8.0% to 8.7%. The Company reaffirmed its
previously provided 2013 adjusted diluted earnings per share from
continuing operations range of $4.85 to $5.00.
A live webcast of the event will be available on the Company’s website
and can be accessed at www.teleflex.com.
A replay of the event and the presentation materials will be available
at the same website following the conclusion of the meeting.
FORECASTED 2014 CONSTANT CURRENCY REVENUE GROWTH RECONCILIATION
|
|
|
|
|
|
|
Low
|
|
|
|
|
High
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Full year 2014 forecasted GAAP revenue growth
|
|
|
|
|
|
6.0%
|
|
|
|
|
8.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange
|
|
|
|
|
|
1.0%
|
|
|
|
|
1.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Full year 2014 forecasted constant currency revenue growth
|
|
|
|
|
|
7.0%
|
|
|
|
|
9.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FORECASTED 2013 CONSTANT CURRENCY REVENUE GROWTH RECONCILIATION
|
|
|
|
|
|
Low
|
|
|
|
|
High
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Full year 2013 forecasted GAAP revenue growth
|
|
|
|
|
8.3%
|
|
|
|
|
9.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange
|
|
|
|
|
(0.3%)
|
|
|
|
|
(0.3%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Full year 2013 forecasted constant currency revenue growth
|
|
|
|
|
8.0%
|
|
|
|
|
8.7%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FORECASTED 2014 EARNINGS PER SHARE RECONCILIATION
|
|
|
|
|
|
|
Low
|
|
|
|
|
High
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share attributable to common shareholders
|
|
|
|
|
|
$3.68
|
|
|
|
|
$3.83
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring, impairment charges and special items, net of tax
|
|
|
|
|
|
$0.65
|
|
|
|
|
$0.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible amortization expense, net of tax
|
|
|
|
|
|
$0.85
|
|
|
|
|
$0.85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of debt discount on convertible notes, net of tax
|
|
|
|
|
|
$0.17
|
|
|
|
|
$0.17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted diluted earnings per share
|
|
|
|
|
|
$5.35
|
|
|
|
|
$5.55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FORECASTED 2013 EARNINGS PER SHARE RECONCILIATION
|
|
|
|
|
|
|
Low
|
|
|
|
|
High
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share attributable to common shareholders
|
|
|
|
|
|
$3.45
|
|
|
|
|
$3.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring, impairment charges and special items, net of tax
|
|
|
|
|
|
$0.50
|
|
|
|
|
$0.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible amortization expense, net of tax
|
|
|
|
|
|
$0.75
|
|
|
|
|
$0.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of debt discount on convertible notes, net of tax
|
|
|
|
|
|
$0.15
|
|
|
|
|
$0.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted diluted earnings per share
|
|
|
|
|
|
$4.85
|
|
|
|
|
$5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ABOUT TELEFLEX INCORPORATED
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Limerick, PA,
Teleflex employs approximately 11,400 people worldwide and serves
healthcare providers in more than 140 countries. For additional
information about Teleflex please refer to: www.teleflex.com.
NOTES ON NON-GAAP FINANCIAL MEASURES
This press release includes certain non-GAAP financial measures. These
measures include (i) forecasted 2013 and 2014 adjusted diluted earnings
per share from continuing operations, which exclude the effect of our
restructuring programs, asset impairments and other special charges,
intangible amortization expense and the amortization of debt discount on
convertible notes ; and (ii) forecasted 2013 and 2014 constant currency
revenue growth, which excludes the impact of translating the results of
international subsidiaries at different currency exchange rates from
period to period. Management believes these measures are useful to
investors because they eliminate items that do not reflect Teleflex’s
day-to-day operations. In addition, management uses these financial
measures for internal managerial purposes, when publicly providing
guidance on possible future results, and to assist in our evaluation of
period-to-period comparisons. These financial measures are presented in
addition to results presented in accordance with GAAP and should not be
relied upon as a substitute for GAAP financial measures. Tables
reconciling these measures to the most directly comparable GAAP measure
are set forth above.
CAUTION CONCERNING FORWARD-LOOKING INFORMATION
This press release contains forward-looking statements, including, but
not limited to, (a) our ability to continue to exceed industry revenue
growth rates and expand adjusted operating margin and earnings per share
in 2014; and (b) forecasted 2013 and 2014 constant currency revenue
growth and adjusted earnings per share from continuing operations.
Actual results could differ materially from those in the forward-looking
statements due to, among other things, conditions in the end markets we
serve, customer reaction to new products and programs, our ability to
achieve sales growth, price increases or cost reductions; changes in the
reimbursement practices of third party payors; our ability to realize
efficiencies and to execute on our strategic initiatives; changes in
material costs and surcharges; market acceptance and unanticipated
difficulties in connection with the introduction of new products and
product line extensions; product recalls; unanticipated difficulties in
connection with the consolidation of manufacturing and administrative
functions; unanticipated difficulties, expenditures and delays in
connection with the integration of acquired businesses, including
unanticipated costs and difficulties in connection with integration
programs and customer reaction; unanticipated difficulties, expenditures
and delays in complying with government regulations applicable to our
businesses; the impact of government healthcare reform legislation; our
ability to meet our debt obligations; changes in general and
international economic conditions; and other factors described or
incorporated in our filings with the Securities and Exchange Commission,
including our Annual Report on Form 10-K for the year ended December 31,
2012.

Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President of Investor Relations
610-948-2836